385 related articles for article (PubMed ID: 24269516)
41. Synthesis and Biological Activity of 2-Amino- and 2-aryl (Heteryl) Substituted 1,3-Benzothiazin-4-ones.
Nosova EV; Lipunova GN; Charushin VN; Chupakhin ON
Mini Rev Med Chem; 2019; 19(12):999-1014. PubMed ID: 30324881
[TBL] [Abstract][Full Text] [Related]
42. Design, synthesis and biological evaluation of novel triazole, urea and thiourea derivatives of quinoline against Mycobacterium tuberculosis.
Upadhayaya RS; Kulkarni GM; Vasireddy NR; Vandavasi JK; Dixit SS; Sharma V; Chattopadhyaya J
Bioorg Med Chem; 2009 Jul; 17(13):4681-92. PubMed ID: 19457676
[TBL] [Abstract][Full Text] [Related]
43. Synthesis, antimycobacterial screening and ligand-based molecular docking studies on novel pyrrole derivatives bearing pyrazoline, isoxazole and phenyl thiourea moieties.
Joshi SD; Dixit SR; Kirankumar MN; Aminabhavi TM; Raju KV; Narayan R; Lherbet C; Yang KS
Eur J Med Chem; 2016 Jan; 107():133-52. PubMed ID: 26580979
[TBL] [Abstract][Full Text] [Related]
44. Direct inhibitors of InhA are active against Mycobacterium tuberculosis.
Manjunatha UH; S Rao SP; Kondreddi RR; Noble CG; Camacho LR; Tan BH; Ng SH; Ng PS; Ma NL; Lakshminarayana SB; Herve M; Barnes SW; Yu W; Kuhen K; Blasco F; Beer D; Walker JR; Tonge PJ; Glynne R; Smith PW; Diagana TT
Sci Transl Med; 2015 Jan; 7(269):269ra3. PubMed ID: 25568071
[TBL] [Abstract][Full Text] [Related]
45. Antimycobacterial activity of natural products and synthetic agents: pyrrolodiquinolines and vermelhotin as anti-tubercular leads against clinical multidrug resistant isolates of Mycobacterium tuberculosis.
Ganihigama DU; Sureram S; Sangher S; Hongmanee P; Aree T; Mahidol C; Ruchirawat S; Kittakoop P
Eur J Med Chem; 2015 Jan; 89():1-12. PubMed ID: 25462220
[TBL] [Abstract][Full Text] [Related]
46. Novel 1-(4-substituted benzylidene)-4-(1-(substituted methyl)-2,3-dioxoindolin-5-yl)semicarbazide derivatives for use against Mycobacterium tuberculosis H37Rv (ATCC 27294) and MDR-TB strain.
Raja S; Prakash CR
Arch Pharm Res; 2013 Apr; 36(4):411-22. PubMed ID: 23440582
[TBL] [Abstract][Full Text] [Related]
47. Discovery of New and Potent InhA Inhibitors as Antituberculosis Agents: Structure-Based Virtual Screening Validated by Biological Assays and X-ray Crystallography.
Kamsri P; Hanwarinroj C; Phusi N; Pornprom T; Chayajarus K; Punkvang A; Suttipanta N; Srimanote P; Suttisintong K; Songsiriritthigul C; Saparpakorn P; Hannongbua S; Rattanabunyong S; Seetaha S; Choowongkomon K; Sureram S; Kittakoop P; Hongmanee P; Santanirand P; Chen Z; Zhu W; Blood RA; Takebayashi Y; Hinchliffe P; Mulholland AJ; Spencer J; Pungpo P
J Chem Inf Model; 2020 Jan; 60(1):226-234. PubMed ID: 31820972
[TBL] [Abstract][Full Text] [Related]
48. Antimycobacterial activity of new 3,5-disubstituted 1,3,4-oxadiazol-2(3H)-one derivatives. Molecular modeling investigations.
Zampieri D; Mamolo MG; Laurini E; Fermeglia M; Posocco P; Pricl S; Banfi E; Scialino G; Vio L
Bioorg Med Chem; 2009 Jul; 17(13):4693-707. PubMed ID: 19467603
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of the inhibitory activity of (aza)isoindolinone-type compounds: toward in vitro InhA action, Mycobacterium tuberculosis growth and mycolic acid biosynthesis.
Chollet A; Stigliani JL; Pasca MR; Mori G; Lherbet C; Constant P; Quémard A; Bernadou J; Pratviel G; Bernardes-Génisson V
Chem Biol Drug Des; 2016 Nov; 88(5):740-755. PubMed ID: 27301022
[TBL] [Abstract][Full Text] [Related]
50. Synthesis and antituberculosis activity of a novel series of optically active 6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles.
Sasaki H; Haraguchi Y; Itotani M; Kuroda H; Hashizume H; Tomishige T; Kawasaki M; Matsumoto M; Komatsu M; Tsubouchi H
J Med Chem; 2006 Dec; 49(26):7854-60. PubMed ID: 17181168
[TBL] [Abstract][Full Text] [Related]
51. Development of selective DprE1 inhibitors: Design, synthesis, crystal structure and antitubercular activity of benzothiazolylpyrimidine-5-carboxamides.
Chikhale R; Menghani S; Babu R; Bansode R; Bhargavi G; Karodia N; Rajasekharan MV; Paradkar A; Khedekar P
Eur J Med Chem; 2015; 96():30-46. PubMed ID: 25874329
[TBL] [Abstract][Full Text] [Related]
52. In vitro antitubercular and antimicrobial activities of 1-substituted quinoxaline-2,3(1H,4H)-diones.
Ramalingam P; Ganapaty S; Rao ChB
Bioorg Med Chem Lett; 2010 Jan; 20(1):406-8. PubMed ID: 19962890
[TBL] [Abstract][Full Text] [Related]
53. Synthesis of Leubethanol derivatives and evaluation against Mycobacterium tuberculosis.
Perez-Meseguer J; Del Olmo E; Alanis-Garza B; Escarcena R; Garza-González E; Salazar-Aranda R; Feliciano AS; de Torres NW
Bioorg Med Chem; 2012 Jul; 20(13):4155-63. PubMed ID: 22626551
[TBL] [Abstract][Full Text] [Related]
54. Substitution of the phosphonic acid and hydroxamic acid functionalities of the DXR inhibitor FR900098: an attempt to improve the activity against Mycobacterium tuberculosis.
Andaloussi M; Lindh M; Björkelid C; Suresh S; Wieckowska A; Iyer H; Karlén A; Larhed M
Bioorg Med Chem Lett; 2011 Sep; 21(18):5403-7. PubMed ID: 21824775
[TBL] [Abstract][Full Text] [Related]
55. Inhibition of the Mycobacterium tuberculosis enoyl acyl carrier protein reductase InhA by arylamides.
He X; Alian A; Ortiz de Montellano PR
Bioorg Med Chem; 2007 Nov; 15(21):6649-58. PubMed ID: 17723305
[TBL] [Abstract][Full Text] [Related]
56. Pyrazole clubbed triazolo[1,5-a]pyrimidine hybrids as an anti-tubercular agents: Synthesis, in vitro screening and molecular docking study.
Bhatt JD; Chudasama CJ; Patel KD
Bioorg Med Chem; 2015 Dec; 23(24):7711-6. PubMed ID: 26631439
[TBL] [Abstract][Full Text] [Related]
57. N-substituted 2-isonicotinoylhydrazinecarboxamides--new antimycobacterial active molecules.
Rychtarčíková Z; Krátký M; Gazvoda M; Komlóová M; Polanc S; Kočevar M; Stolaříková J; Vinšová J
Molecules; 2014 Mar; 19(4):3851-68. PubMed ID: 24686575
[TBL] [Abstract][Full Text] [Related]
58. Novel 1,4-substituted-1,2,3-triazoles as antitubercular agents.
Altimari JM; Hockey SC; Boshoff HI; Sajid A; Henderson LC
ChemMedChem; 2015 May; 10(5):787-91. PubMed ID: 25788466
[TBL] [Abstract][Full Text] [Related]
59. Synthesis and antitubercular activity of novel amino acid derivatives.
Da Costa CF; Pinheiro AC; De Almeida MV; Lourenço MC; De Souza MV
Chem Biol Drug Des; 2012 Feb; 79(2):216-22. PubMed ID: 22078007
[TBL] [Abstract][Full Text] [Related]
60. Synthesis and Structure-Activity Relationship Studies of C2-Modified Analogs of the Antimycobacterial Natural Product Pyridomycin.
Kienle M; Eisenring P; Stoessel B; Horlacher OP; Hasler S; van Colen G; Hartkoorn RC; Vocat A; Cole ST; Altmann KH
J Med Chem; 2020 Feb; 63(3):1105-1131. PubMed ID: 31904960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
